Auxocell continues to be an innovator in the regenerative-medicine field with the release of its Auxocell Processing (AC:Px) System, a patented tool for processing solid tissue. The Auxocell research team relied upon their decades of experience in solid-tissue processing to design and manufacture the AC:Px. The AC:PX system is available exclusively from Auxocell.
- Kyle Cetrulo Chief Executive Officer
- Rouzbeh R. Taghizadeh, PhD Chief Scientific Officer